Keyphrases
Acute Promyelocytic Leukemia
100%
Meeting Report
100%
School of Medicine
50%
Northwestern University
33%
Chicago
33%
Bleeding
33%
Oncohematology
33%
Hematology
33%
Early Death
33%
Bergamo
33%
Cancer Center
16%
Medical Center
16%
Therapeutic Agents
16%
Chemotherapy
16%
All-trans Retinoic Acid
16%
Thrombosis
16%
Israel
16%
Improved Outcomes
16%
Patient Management
16%
Current Treatment
16%
Biological Aspects
16%
Italy
16%
Major Complications
16%
Randomized Controlled Trial
16%
Hyperactivity
16%
Washington DC
16%
University of Southern California
16%
Successful Treatment
16%
Clinical Aspects
16%
Prophylactic Treatment
16%
Coagulation
16%
Leukemia Cells
16%
Specific Proteolytic Activity
16%
Saint Louis
16%
Fibrinolytic System
16%
Spain
16%
Madrid
16%
Coagulopathy
16%
Coagulation System
16%
Chemotherapy Alone
16%
Life-threatening Bleeding
16%
New Anticoagulants
16%
Hyperfibrinolysis
16%
Haifa
16%
Falanga
16%
George Washington
16%
Paris France
16%
Medicine and Dentistry
Acute Promyelocytic Leukemia
100%
Hematology
66%
Medicine
50%
Chemotherapy
33%
Bleeding
33%
Division
33%
Oncology
33%
Leukemia Cell
16%
Prophylaxis
16%
Therapeutic Agent
16%
Blood Clotting
16%
Protein Degradation
16%
Malignant Neoplasm
16%
Coagulopathy
16%
Thrombosis
16%
Fibrinolysis
16%
Tretinoin
16%
Hyperactivity
16%
Hyperfibrinolysis
16%
Randomized Controlled Trial
16%
Anticoagulant
16%
Pharmacology, Toxicology and Pharmaceutical Science
Promyelocytic Leukemia
100%
Chemotherapy
33%
Bleeding
33%
Leukemia
16%
Randomized Controlled Trial
16%
Malignant Neoplasm
16%
Anticoagulant Agent
16%
Retinoic Acid
16%
Hyperactivity
16%
Fibrinolytic Agent
16%
Blood Clotting Disorder
16%
Thrombosis
16%